Future studies examining the presence of amyloid (eg, through the use of Pittsburgh compound B positron emission tomography scans in vivo, or analysis at autopsy) or genetic markers of dementia such as apolipoprotein E (APOE) status in people with TEA may shed light on the inter‐relationships between these two clinical conditions. Here, APOE is linked to dementia.